Terrien's marginal degeneration
| Terrien's marginal degeneration | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Blurred vision, astigmatism, corneal thinning |
| Complications | Corneal perforation |
| Onset | Typically in the second to third decade of life |
| Duration | Progressive |
| Types | |
| Causes | Unknown |
| Risks | |
| Diagnosis | Slit-lamp examination, corneal topography |
| Differential diagnosis | Keratoconus, pellucid marginal degeneration |
| Prevention | |
| Treatment | Contact lenses, corneal transplantation |
| Medication | |
| Prognosis | Variable, can lead to significant visual impairment |
| Frequency | Rare |
| Deaths | N/A |
Terrien's marginal degeneration is a rare, slowly progressive condition that affects the cornea, the clear front surface of the eye. It is characterized by thinning (degeneration) of the peripheral corneal stroma, leading to a characteristic appearance of the cornea. The condition is typically bilateral and asymmetric, and it usually begins in the superior cornea. The cause of Terrien's marginal degeneration is unknown.
Signs and Symptoms[edit]
Patients with Terrien's marginal degeneration may initially be asymptomatic, but as the condition progresses, they may experience decreased vision, irregular astigmatism, and in severe cases, corneal perforation. The condition is typically diagnosed through a comprehensive eye examination, including slit-lamp examination and corneal topography.
Treatment[edit]
The treatment of Terrien's marginal degeneration is primarily aimed at managing the symptoms and preventing further progression of the disease. This may include the use of glasses or contact lenses to correct irregular astigmatism, and in severe cases, corneal transplantation may be necessary.
Epidemiology[edit]
Terrien's marginal degeneration is a rare condition, with an estimated prevalence of less than 1 in 200,000. It typically affects adults in their fourth or fifth decade of life, and it is more common in men than in women.
See Also[edit]
References[edit]
<references />
This <a href="/wiki/Rare_disease" title="Rare disease">rare disease</a>-related article is a <a href="/wiki/Stub" title="Stub">stub</a>. You can help <a href="/wiki/WikiMD" title="WikiMD">WikiMD</a> by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
